Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group

BACKGROUND: Surgery can cure a significant percentage of ovarian carcinoma confined to the pelvis. Nevertheless, there is still a 10–50% recurrence rate. We administered paclitaxel/carboplatin as adjuvant treatment in early-stage ovarian carcinoma. METHODS: Patients with stages Ia or Ib, Grade 2 or...

Descripción completa

Detalles Bibliográficos
Autores principales: Bamias, Aristotle, Papadimitriou, Christos, Efstathiou, Eleni, Rodolakis, Alexandros, Vlahos, Georgios, Voulgaris, Zannis, Bozas, Georgios, Fountzilas, Georgios, Aravantinos, Gerassimos, Razis, Evagelia, Gika, Dimitra, Dimopoulos, Meletios A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592509/
https://www.ncbi.nlm.nih.gov/pubmed/16999858
http://dx.doi.org/10.1186/1471-2407-6-228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592509/
https://www.ncbi.nlm.nih.gov/pubmed/16999858
http://dx.doi.org/10.1186/1471-2407-6-228

Ejemplares similares